MedPath

TERIFLUNOMIDA AUROVITAS 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

TERIFLUNOMIDA AUROVITAS 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

89846

Prescription Type

Uso Hospitalario

Authorization Date

Sep 30, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89846
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TERIFLUNOMIDAActive
Quantity: 14 mg
Name: TERIFLUNOMIDA

ATC CLASSIFICATION (3)

L04A
L04AK
L04AK02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.